Search Result "Inhibit EGFR Activity"
Review on EGFR Inhibitors: Critical Updates
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16 Issue: 14 Year: 2016 Page: 1134-1166
Author(s): Davinder Singh,Bhupinder Kumar Attri,Rupinder Kaur Gill,Jitender Bariwal
Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis,In-Vitro Inhibition, and Molecular Modeling Studies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 2 Year: 2022 Page: 328-343
Author(s): Akshada Joshi,Heena Bhojwani,Ojas Wagal,Khushboo Begwani,Urmila Joshi,Sadhana Sathaye,Divya Kanchan
Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 8 Year: 2009 Page: 931-937
Author(s): J. Kao, A. T. Sikora, S. Fu
Small Molecules with EGFR-TK Inhibitor Activity
Journal: Current Drug Targets
Volume: 6 Issue: 3 Year: 2005 Page: 259-274
Author(s): Joan Albanell, Pere Gascon
Insight into the Medicinal Chemistry of EGFR and HER-2 Inhibitors
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 11 Year: 2014 Page: 1336-1350
Author(s): C. Wang,H. Gao,J. Dong,F. Wang,P. Li,J. Zhang
Prediction Oriented QSAR Modelling of EGFR Inhibition
Journal: Current Medicinal Chemistry
Volume: 13 Issue: 3 Year: 2006 Page: 277-287
Author(s): C. Szantai-Kis, I. Kovesdi, D. Eros, P. Banhegyi, A. Ullrich, G. Keri, L. Orfi
Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 176-191
Author(s): R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio, M. Casto
Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2983-2998
Author(s): Eyal Mishani, Galith Abourbeh, Martin Eiblmaier, Carolyn J. Anderson
Inhibitory Activity Against Epidermal Growth Factor Receptor (EGFR) Based on Single Point Mutations of Active Site Residues
Journal: Medicinal Chemistry
Volume: 10 Issue: 3 Year: 2014 Page: 252-270
Author(s): Petar M. Mitrasinovic
Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity
Journal: Current Cancer Therapy Reviews
Volume: 3 Issue: 4 Year: 2007 Page: 236-241
Author(s): Teresa Troiani, Tina Cascone, John Heymach, Fortunato Ciardiello